Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Structural & Congenital Heart Disease: In-hospital stroke rates | COVID-19 | Skip the clopidogrel?
Friday, January 8, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Structural Heart Disease

Top Stories

In-hospital stroke rates higher after TAVR than MitraClip procedures

Post-discharge stroke rates, however, were similar between the two procedures.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

In-hospital stroke rates higher after TAVR than MitraClip procedures

Share on Twitter Share on Facebook Share on Linkedin
Post-discharge stroke rates, however, were similar between the two procedures.
READ MORE >

American College of Cardiology, American Heart Association share new recommendations for managing valvular heart disease

The new document, published in both the Journal of the American College of Cardiology and Circulation, highlights the significant progress researchers and clinicians have made in this area in recent years.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

American College of Cardiology, American Heart Association share new recommendations for managing valvular heart disease

Share on Twitter Share on Facebook Share on Linkedin
The new document, published in both the Journal of the American College of Cardiology and Circulation, highlights the significant progress researchers and clinicians have made in this area in recent years.
READ MORE >

How COVID-19 may affect patients with adult congenital heart disease

This new position paper is a collaboration between representatives from the European Society of Cardiology and International Society for Adult Congenital Heart Disease.

READ MORE >
Covid Hospital
Share on Twitter Share on Facebook Share on Linkedin

How COVID-19 may affect patients with adult congenital heart disease

Share on Twitter Share on Facebook Share on Linkedin
Covid Hospital
This new position paper is a collaboration between representatives from the European Society of Cardiology and International Society for Adult Congenital Heart Disease.
READ MORE >

Edwards evaluating the safety, effectiveness of new mitral valve repair solution

The system was designed to require only one small incision to repair a patient’s mitral valve. 

READ MORE >
heart.png
Share on Twitter Share on Facebook Share on Linkedin

Edwards evaluating the safety, effectiveness of new mitral valve repair solution

Share on Twitter Share on Facebook Share on Linkedin
heart.png
The system was designed to require only one small incision to repair a patient’s mitral valve. 
READ MORE >

Scientists share new data on how gene mutations lead to congenital heart disease

The analysis explored key gene mutations as they occur in human heart cells. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Scientists share new data on how gene mutations lead to congenital heart disease

Share on Twitter Share on Facebook Share on Linkedin
The analysis explored key gene mutations as they occur in human heart cells. 
READ MORE >

Skip the clopidogrel? TAVR patients benefit from antiplatelet therapy that includes aspirin only

The risk of major bleeding or life-threatening bleeding events was higher when clopidogrel was included in the patient's treatment strategy. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Skip the clopidogrel? TAVR patients benefit from antiplatelet therapy that includes aspirin only

Share on Twitter Share on Facebook Share on Linkedin
The risk of major bleeding or life-threatening bleeding events was higher when clopidogrel was included in the patient's treatment strategy. 
READ MORE >

Scientists share breakthrough that could limit heart valve disease, help patients avoid replacement surgery

After 15 years of dedicated research, a cardiologist-led team of scientists thinks their work could dramatically change patient care.

READ MORE >
patient with heart doctor
Share on Twitter Share on Facebook Share on Linkedin

Scientists share breakthrough that could limit heart valve disease, help patients avoid replacement surgery

Share on Twitter Share on Facebook Share on Linkedin
patient with heart doctor
After 15 years of dedicated research, a cardiologist-led team of scientists thinks their work could dramatically change patient care.
READ MORE >

Aortic stenosis patients with AFib may experience more complications after valve replacement

The analysis, published in the American Journal of Cardiology, included data from more than 741,000 adult patients with aortic stenosis. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Aortic stenosis patients with AFib may experience more complications after valve replacement

Share on Twitter Share on Facebook Share on Linkedin
The analysis, published in the American Journal of Cardiology, included data from more than 741,000 adult patients with aortic stenosis. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme